Xylem (NYSE:XYL) Reports Q2 CY2026 In Line With Expectations
Xylem (NYSE:XYL) reported Q2 CY2026 results. Revenue rose 1.5% year on year to $2.34 billion, matching Wall Street expectations. Full-year revenue guidance was $9.2 billion at the midpoint, 0.6% below analysts’ estimates. Non-GAAP adjusted EPS was $1.46, up from $1.26, beating consensus by 9.2%.
How this was made
The 30-second read
Why it matters
The key tradable inputs are the Q2 adjusted EPS beat versus consensus and the full-year revenue guidance coming in slightly below analysts at the midpoint, alongside operating margin expansion.
Market read
This is a mixed earnings-and-guidance update that can drive near-term positioning around EPS leverage versus revenue growth expectations.
What to watch
The text notes EBITDA missed and revenue growth decelerated over two years; traders may want to verify whether backlog, pricing, or mix explains the guidance gap.
Background
Xylem is a water technology company reporting Q2 CY2026 results, including revenue, adjusted EPS, and full-year guidance.
Ticker impact
Xylem reported Q2 adjusted EPS of $1.46 (9.2% above consensus) and guided full-year revenue to $9.2B midpoint, 0.6% below estimates.
Likely choppy follow-through rather than a sustained trend, with focus shifting to whether revenue shortfall is temporary.
The article provides a concrete EPS beat and margin expansion, but also a specific full-year revenue guidance miss versus analysts, which can cap upside despite the EPS outperformance.
Market effects
Water infrastructure and industrials demand expectations may be read through Xylem’s decelerating growth narrative.
No specific regional demand or regulatory driver is disclosed.
No explicit global macro or international contract detail is provided.
Counterpoint
The revenue guidance miss is small (0.6% below estimates) and could be offset by continued EPS leverage and margin efficiency.
Key entities
- companyXylem
Reported Q2 CY2026 results and provided full-year revenue and EPS outlook.
